SIRT6 and neoplasm: When tested in a mouse xenograft modelwith human DLBCL cells, 19b reduced tumor growth anddecreased the levels of the proliferative marker Ki-67.79 Nevertheless, these reports lack of target engagementstudies demonstrating that 19b does bind to SIRT6 atleast in the cellular context.